← Back to Search

Behavioural Intervention

Fasting for Healthy Subjects

N/A

Recruiting

Led By Gurinder Bains, PhD

Research Sponsored by Loma Linda University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change between baseline and eight weeks

Awards & highlights

Study Summary

"This trial is looking into whether intermittent fasting can help with losing body fat and improving quality of life."

Who is the study for?

This trial is for healthy individuals who want to participate in a study examining the effects of intermittent fasting on body fat reduction and life quality. People with metabolic syndrome or diabetes cannot join.Check my eligibility

What is being tested?

The study is testing whether not eating food for certain periods (intermittent fasting) can help reduce body fat and improve how good participants feel about their lives compared to those who do not fast.See study design

What are the potential side effects?

Intermittent fasting may lead to temporary side effects such as hunger, fatigue, irritability, headaches, or dizziness due to changes in eating patterns.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change between baseline and eight weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change between baseline and eight weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and change between baseline and eight weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Body fat percentage

Visceral fat

Side effects data

From 2015 Phase 4 trial • 15 Patients • NCT01380366

Hospitalization for Escherichia coli Infection

Hospitalization for Gram-positive Cocci

Hospitalization for positive line infection

Pancreatitis

Hospitalization for abdominal pain (pre-treatment)

Hospitalization for Flu like Symptoms

100%

80%

60%

40%

20%

Study treatment Arm

Patients Consented to be Given rHGH

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: FastingExperimental Treatment1 Intervention

For four weeks: Fasting for 16 hours from participant last meal of the previous evening's meal to the first meal of the next day. Then for 8 hours, participant is able to eat. During the fasting, participants are allowed to consume water and black coffee/tea. Participants will also keep their normal weekly exercise routine.

Group II: Non FastingActive Control1 Intervention

For four week: Participants will keep their normal food intake with no restrictions on when to eat. Participants will keep their normal weekly exercise routine.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor

306 Previous Clinical Trials

260,914 Total Patients Enrolled

Gurinder Bains, PhDPrincipal InvestigatorLoma Linda University

3 Previous Clinical Trials

92 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the clinical trial open to individuals aged 75 and older?

"To be considered for enrollment in this investigation, individuals must have reached the age of 18 but not exceed 65 years."

Answered by AI

Are there any available slots for patients to participate in this clinical trial?

"Indeed, information on clinicaltrials.gov highlights that this study is actively seeking participants. The trial was originally posted on March 11th, 2024 and most recently updated on March 5th, 2024. They aim to recruit a total of 70 individuals at one designated site."

Answered by AI

What is the current number of participants involved in this research investigation?

"Indeed, the details on clinicaltrials.gov highlight that this particular clinical trial is currently open for patient recruitment. The study was first listed on March 11th, 2024, and last revised on March 5th, 2024. A total of 70 participants are sought at a single designated site."

Answered by AI